69 related articles for article (PubMed ID: 21554418)
1. Activation of the human complement system by pigmented and hypopigmented mycelia of the fungus Fonsecaea pedrosoi.
Pinto L; Granja LF; Alviano DS; da Silva MH; Alviano CS; Ejzemberg R
Mycoses; 2011 Sep; 54(5):e474-80. PubMed ID: 21554418
[TBL] [Abstract][Full Text] [Related]
2. Melanin particles isolated from the fungus Fonsecaea pedrosoi activates the human complement system.
Pinto L; Granja LFZ; Almeida MA; Alviano DS; Silva MHD; Ejzemberg R; Rozental S; Alviano CS
Mem Inst Oswaldo Cruz; 2018 Jun; 113(8):e180120. PubMed ID: 29947713
[TBL] [Abstract][Full Text] [Related]
3. Secretory aspartyl peptidase activity from mycelia of the human fungal pathogen Fonsecaea pedrosoi: effect of HIV aspartyl proteolytic inhibitors.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
Res Microbiol; 2006 Nov; 157(9):819-26. PubMed ID: 16959473
[TBL] [Abstract][Full Text] [Related]
4. The major chromoblastomycosis fungal pathogen, Fonsecaea pedrosoi, extracellularly releases proteolytic enzymes whose expression is modulated by culture medium composition: implications on the fungal development and cleavage of key's host structures.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):21-9. PubMed ID: 16420593
[TBL] [Abstract][Full Text] [Related]
5. Effect of different temperature and culture media on the growth of Macrophomina phaseolina.
Csöndes I; Kadlicskó S; Gáborjányi R
Commun Agric Appl Biol Sci; 2007; 72(4):839-48. PubMed ID: 18396819
[TBL] [Abstract][Full Text] [Related]
6. Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes.
Alviano DS; Franzen AJ; Travassos LR; Holandino C; Rozental S; Ejzemberg R; Alviano CS; Rodrigues ML
Infect Immun; 2004 Jan; 72(1):229-37. PubMed ID: 14688100
[TBL] [Abstract][Full Text] [Related]
7. Activation of the alternative complement pathway by Fonsecaea pedrosoi.
Torinuki W; Okohchi K; Takematsu H; Tagami H
J Invest Dermatol; 1984 Oct; 83(4):308-10. PubMed ID: 6481182
[TBL] [Abstract][Full Text] [Related]
8. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural characterization of melanosomes of the human pathogenic fungus Fonsecaea pedrosoi.
Franzen AJ; Cunha MM; Miranda K; Hentschel J; Plattner H; da Silva MB; Salgado CG; de Souza W; Rozental S
J Struct Biol; 2008 Apr; 162(1):75-84. PubMed ID: 18096404
[TBL] [Abstract][Full Text] [Related]
11. Development of natural culture media for rapid induction of Fonsecaea pedrosoi sclerotic cells in vitro.
da Silva MB; da Silva JP; Sirleide Pereira Yamano S; Salgado UI; Diniz JA; Salgado CG
J Clin Microbiol; 2008 Nov; 46(11):3839-41. PubMed ID: 18799695
[TBL] [Abstract][Full Text] [Related]
12. Complement and complement regulatory proteins in human tears.
Willcox MD; Morris CA; Thakur A; Sack RA; Wickson J; Boey W
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):1-8. PubMed ID: 9008624
[TBL] [Abstract][Full Text] [Related]
13. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
14. Activation of the complement system in normal pregnancy and preeclampsia.
Derzsy Z; Prohászka Z; Rigó J; Füst G; Molvarec A
Mol Immunol; 2010 Apr; 47(7-8):1500-6. PubMed ID: 20181396
[TBL] [Abstract][Full Text] [Related]
15. Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides.
Nimrichter L; Cerqueira MD; Leitão EA; Miranda K; Nakayasu ES; Almeida SR; Almeida IC; Alviano CS; Barreto-Bergter E; Rodrigues ML
Infect Immun; 2005 Dec; 73(12):7860-8. PubMed ID: 16299276
[TBL] [Abstract][Full Text] [Related]
16. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
[TBL] [Abstract][Full Text] [Related]
17. Melanin in Fonsecaea pedrosoi: a trap for oxidative radicals.
Cunha MM; Franzen AJ; Seabra SH; Herbst MH; Vugman NV; Borba LP; de Souza W; Rozental S
BMC Microbiol; 2010 Mar; 10():80. PubMed ID: 20233438
[TBL] [Abstract][Full Text] [Related]
18. Effect of environmental factors on Fonsecaea pedrosoi morphogenesis with emphasis on sclerotic cells induced by propranolol.
Alviano CS; Farbiarz SR; Travassos LR; Angluster J; de Souza W
Mycopathologia; 1992 Jul; 119(1):17-23. PubMed ID: 1406903
[TBL] [Abstract][Full Text] [Related]
19. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
[TBL] [Abstract][Full Text] [Related]
20. Complement component 9 activation, consumption, and neuronal deposition in the post-hypoxic-ischemic central nervous system of human newborn infants.
Schultz SJ; Aly H; Hasanen BM; Khashaba MT; Lear SC; Bendon RW; Gordon LE; Feldhoff PW; Lassiter HA
Neurosci Lett; 2005 Apr; 378(1):1-6. PubMed ID: 15763162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
